OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways
József Király, Erzsébet Szabó, Petra Fodor, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6725-6725
Open Access | Times Cited: 9
József Király, Erzsébet Szabó, Petra Fodor, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6725-6725
Open Access | Times Cited: 9
Showing 9 citing articles:
Improving the quality of quantitative polymerase chain reaction experiments: 15 years of MIQE
Stephen A. Bustin
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101249-101249
Open Access | Times Cited: 11
Stephen A. Bustin
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101249-101249
Open Access | Times Cited: 11
Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: An update since 2020
Yanqing Liu, Jie Chen, Xiang Li, et al.
Pharmacological Research (2025) Vol. 212, pp. 107577-107577
Open Access
Yanqing Liu, Jie Chen, Xiang Li, et al.
Pharmacological Research (2025) Vol. 212, pp. 107577-107577
Open Access
Investigating the Role of Shikonin in Enhancing Osteogenesis and Angiogenesis for the Treatment of Osteoporosis
Xiongke Hu, Qian Tan, Guanghui Zhu, et al.
ACS Omega (2025)
Open Access
Xiongke Hu, Qian Tan, Guanghui Zhu, et al.
ACS Omega (2025)
Open Access
Renal cancer: signaling pathways and advances in targeted therapies
Aimin Jiang, Jinxin Li, Ziwei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Aimin Jiang, Jinxin Li, Ziwei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies
Saeid Iranzadeh, Davood Dalil, Soroush Kohansal, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 8, pp. 967-982
Open Access | Times Cited: 3
Saeid Iranzadeh, Davood Dalil, Soroush Kohansal, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 76, Iss. 8, pp. 967-982
Open Access | Times Cited: 3
Comprehensive prognostic assessment in kidney cancer: A multidimensional approach analyzing Fufang Sanling granules, genetic variants, and immune infiltration
Junlan Zhu, Yun Ye, Xin Zhao, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3694-3709
Closed Access
Junlan Zhu, Yun Ye, Xin Zhao, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3694-3709
Closed Access
Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species
Qi Ke, Jiayi Li, Yang Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Qi Ke, Jiayi Li, Yang Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Bioavailability and Pharmacological Properties of Shikonin‐ A Phytocompound from Lithospermum Erythrorhizon
Stuti Biswal, Bijesh K. Biswal
ChemistrySelect (2024) Vol. 9, Iss. 45
Closed Access
Stuti Biswal, Bijesh K. Biswal
ChemistrySelect (2024) Vol. 9, Iss. 45
Closed Access
The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model
Birgit Lohberger, Heike Kaltenegger, Nicole Eck, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15910-15910
Open Access | Times Cited: 1
Birgit Lohberger, Heike Kaltenegger, Nicole Eck, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15910-15910
Open Access | Times Cited: 1
